In vitro effects of a flavonoid-rich extract on LDL oxidation

Atherosclerosis

Volumn 123, Issue 1-2, 1996, Pages 83-91

  Viana, Marta ^a   Barbas, Coral ^a   Bonet, Bartolomé ^a,b   Bonet, M Victoria ^a   Castro, Mario ^a   Fraile, M Victoria ^a   Herrera, Emilio ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Cardiovascular disease; Flavonoids; Oxidized LDL

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BUTYLCRESOL; EDETIC ACID; FLAVONOID; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET; ELECTROPHORESIS; HUMAN; IN VITRO STUDY; LIPID OXIDATION; PRIORITY JOURNAL;

EID: 0029922614     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05763-3     Document Type: Article

References (35)

1. Carew TE. Role of biologically modified low-density lipoprotein in atherosclerosis. Am J Cardiol 1989;64:18G.
2. Steinbrecher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 1990;9:155.
3. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med 1989;320:915.
4. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 1980;77:2214.
5. Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witztum JL. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest 1991;87:90.
6. Trevor-Malden L, Chait A, Raines El W, Ross R. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. J Biol Chem 1991;266:13901.
7. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, Fogelman AM. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 1991;87:2253.
8. Chisolm GM. Cytotoxicity of oxidized lipoproteins. Curr Opin Lipidol 1991;2:215.
9. Henriksen T, Evensen SA, Carlande B. Injury to human endothelial cells in culture induced by low density lipoproteins. Scand J Clin Lab Invest 1979;39:361.
10. Jialal I, Scaccini C. Antioxidants and atherosclerosis. Curr Opin Lipidol 1992;3:324.
11. Jialal I, Grundy S. The effect of dietary supplementation with alpha-tocopherol in the oxidative modification of low-density lipoprotein. J Lipid Res 1992;33:899.
12. Esterbauer H, Puhl H, Cieber-Rotheneder M, Waeg G, Rabl H. Effect of antioxidants on oxidative modification of LDL. Ann Med 1991;23:573.
13. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53:326S.
14. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991;337:1.
15. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. New Engl J Med 1993;328:1444.
16. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Golditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med 1993;328:1450.
17. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. In: Packer L and Glazer AN (eds). Methods Enzymol 1990;186:343.
18. Myara I, Píco B, Moatti N. A method to screen for the antioxidant effect of compounds on low density lipoprotein (LDL): illustration with flavonoids. J Pharmacol Toxicol Methods 1993;30:69.
19. Renaud D, De Lorgeril M. Wine, alcohol, platelets, and the French Paradox for coronary heart disease. Lancet 1992;339:1523.
20. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454.
21. Hertog M, Feskens E, Hollman P, Katan M, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 1993;342:1007.
22. De Whalley CV, Rankin SM, Robin J, Hoult S, Jessup W, Leake DS. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 1990;39:1743.
23. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Kraus RM, Beaudrie K, Cone JT. Single vertical spin density gradient ultracentrifugation. Methods Enzymol 1986;128:181.
24. Esterbauer H, Striegl G, Publ H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265.
26. Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediated modifications of low density lipoprotein by arterial smooth muscle cells. J Clin Invest 1986;77:757.
27. Cuesta D, Castro M. Simultaneous measurement of retinol and alfa-tocopherol in human serum by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 1986;380:145.
28. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alfa-tocopherol and ascorbate. Arch Biochem Biophys 1993;300:535.
29. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341.
30. Stait SE, Leake DE. Ascorbic acid can either increase or decrease low density lipoprotein modification. FEBS Lett 1994;341:263.
31. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford: Clarendon Press, 1989.
32. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: an overview. In: Packer L and Glazer AN (eds). Methods Enzymol, 1990;186:1.
33. Kalyanaraman B, Darley-Usmar VM, Wood J, Joseph J, Parthasarathy S. Synergistic interaction between the probucol phenoxyl radical and ascorbic acid in inhibiting the oxidation of low density lipoprotein. J Biol Chem 1992;267:6789.
34. Ishwarlal J, Grundy SM. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 1991;87:597.
35. Kagan VE, Serbinova EA, Forte T, Scita S, Packer L. Recycling of vitamin E in human low density lipoproteins. J Lipid Res 1992;33:385.